Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NY:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
5.900 - 9.200
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
UPDATE: Aegis Capital Lowers Pernix Therapeutics PT on Reduced Company Guidance
May 20, 2013
In a report published Monday, Aegis Capital analyst Raghuram Selvaraju maintained the rating of Buy, and lowered the price target on Pernix Therapeutics (NASDAQ: PTX ) to $8.50. In the report, Aegis...
Read More
category
PTX
,
Benzinga
,
Raghuram Selvaraju
, and 4 more.
from
Latest Articles from Benzinga.com
UPDATE: Cantor Fitzgerald Lowers PT on Pernix Therapeutics after Mike Pearce Named CEO
May 15, 2013
In a report published Wednesday morning, Cantor Fitzgerald analyst Irina Rivkind reiterated a Hold rating on Pernix Therapeutics (NASDAQ: PTX ) and lowered the price target from $7 to $3. In the...
Read More
category
PTX
,
Cantor Fitzgerald
,
Benzinga
, and 3 more.
from
Latest Articles from Benzinga.com
More News
Read More
Pernix Therapeutics Reports First Quarter 2013 Financial Results
May 10, 2013
from
Business Wire News Releases
Pernix Therapeutics to Report First Quarter 2013 Financial Results on May 10, 2013
May 03, 2013
from
Business Wire News Releases
Laboratoires Paladin annonce le lancement de Silenor(MD) au Canada
May 01, 2013
from
Marketwired
Paladin Labs Announces the Canadian Launch of Silenor(R)
May 01, 2013
from
Marketwired News Releases
Pernix Therapeutics to Present at the 12th Annual Needham Healthcare Conference
April 23, 2013
from
Business Wire News Releases
Cantor Fitzgerald Downgrades Pernix Therapeutics (PTX) to Hold
March 19, 2013
from
StreetInsider.com News Articles
Pfizer (PFE), Protalix (PTX) UPLYSO Receives Approval in Brazil
March 18, 2013
from
StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 03/18: (ULTR) (PRWT) (SPMD) Higher; (AMBO) (PTX) (UTSI) Lower
March 18, 2013
from
StreetInsider.com News Articles
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here